These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

756 related articles for article (PubMed ID: 4166664)

  • 1. Chronic hemolytic anemia due to cold agglutinins: the mechanism of resistance of red cells to C' hemolysis by cold agglutinins.
    Evans RS; Turner E; Bingham M
    J Clin Invest; 1967 Sep; 46(9):1461-74. PubMed ID: 4166664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic hemolytic anemia due to cold agglutinins. II. The role of C' in red cell destruction.
    Evans RS; Turner E; Bingham M; Woods R
    J Clin Invest; 1968 Apr; 47(4):691-701. PubMed ID: 5641611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The reaction mechanism of beta-1C-globulin (C'3) in immune hemolysis.
    Müllerèberhard HJ; Dalmasso AP; Calcott MA
    J Exp Med; 1966 Jan; 123(1):33-54. PubMed ID: 4159289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. INTERACTIONS BETWEEN 131-I TRACE-LABELLED COLD AGGLUTININ, COMPLEMENT AND RED CELLS.
    HARBOE M
    Br J Haematol; 1964 Jul; 10():339-46. PubMed ID: 14179488
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemolytic anemia associated with multiple autoantibodies and low serum complement.
    Moake JL; Schultz DR
    Am J Med; 1975 Mar; 58(3):431-7. PubMed ID: 1078754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the antigenic properties of complement. II. Analysis of specific agglutinins against certain components of guinea pig complement fixed on sensitized sheep erythrocytes.
    KLEIN PG; BURKHOLDER PM
    J Exp Med; 1960 Jan; 111(1):107-17. PubMed ID: 14409703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical properties of the red cell agglutinins in acquired hemolytic anemia.
    FUDENBERG HH; KUNKEL HG
    J Exp Med; 1957 Nov; 106(5):689-702. PubMed ID: 13475624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic significance of the direct antiglobulin test (DAT) in anemic dogs.
    Slappendel RJ
    Vet Immunol Immunopathol; 1979 Nov; 1(1):49-59. PubMed ID: 15612269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The resistance of C'-142 coated cells to complement hemolysis by cold agglutinin.
    Evans RS; Turner E; Bingham M
    Bibl Haematol; 1965; 23():834-9. PubMed ID: 5879447
    [No Abstract]   [Full Text] [Related]  

  • 10. Measurement of the third component of complement bound to red blood cells in patients with the cold agglutinin syndrome.
    Logue GL; Rosse WF; Gockerman JP
    J Clin Invest; 1973 Feb; 52(2):493-501. PubMed ID: 4734261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of complement by cold agglutinins.
    Kirschfink M; Knoblauch K; Roelcke D
    Infusionsther Transfusionsmed; 1994 Dec; 21(6):405-9. PubMed ID: 7873919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemolysis in cold agglutinin disease: the role of C' and cell age in red cell destruction.
    Dudok de Wit C; Van Gastel C
    Br J Haematol; 1970 May; 18(5):557-66. PubMed ID: 5430344
    [No Abstract]   [Full Text] [Related]  

  • 13. COLD AGGLUTININ DISEASE. A REPORT OF SPONTANEOUS REMISSION.
    GOTTLIEB LH
    Calif Med; 1964 Aug; 101(2):120-3. PubMed ID: 14180493
    [No Abstract]   [Full Text] [Related]  

  • 14. STUDIES WITH I-131 TAGGED COLD AGGLUTININS.
    EVANS RS; TURNER E; BINGHAM M
    Bibl Haematol; 1964; 19():347-51. PubMed ID: 14267026
    [No Abstract]   [Full Text] [Related]  

  • 15. [Fulminant autoimmune cold-type hemolysis with marked elevation of monothermic cold agglutinins. Successful therapy with membrane plasmapheresis].
    Gordjani N; Kretschmer V; Töllner U; Rieger C
    Monatsschr Kinderheilkd; 1990 Aug; 138(8):454-6. PubMed ID: 2215510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serologic diagnosis in the differentiation of autoimmune hemolytic anemias.
    Gologan R; Berceanu S
    Med Interne; 1979; 17(2):191-6. PubMed ID: 472642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo metabolism of complement. I. Metabolism of the third component (C'3) in acquired hemolytic anemia.
    Petz LD; Fink DJ; Letsky EA; Fudenberg HH; Müller-Eberhard J
    J Clin Invest; 1969 Nov; 47(11):2469-84. PubMed ID: 4975569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement activation by cold agglutinins.
    Kirschfink M; Fritze H; Roelcke D
    Vox Sang; 1992; 63(3):220-6. PubMed ID: 1448966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the mechanism of hemolytic anemia and hemoglobinuria occurring in patients with high concentrations of serum cold agglutinins.
    HAM TH; GARDNER FH
    J Clin Invest; 1948 Jul; 27(4):538. PubMed ID: 18935158
    [No Abstract]   [Full Text] [Related]  

  • 20. Red cell destruction in cold agglutinin disease.
    Zilow G; Kirschfink M; Roelcke D
    Infusionsther Transfusionsmed; 1994 Dec; 21(6):410-5. PubMed ID: 7873920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.